Comparing RRFFC between GQ PDDTURBT and GQ WLTURBT

Comparing RRFFC between GQ-PDDTURBT and GQ-WLTURBT in low- and intermediate-risk tumorsNMIBC Risk CategoryRRFFC for GQWL-TURBT, n (%)RRFFC for GQ-PDDTURBT, n (%)OR (95% CI); PLow risk (G1/G2 Ta, single and <3 cm)15/68 (22.1)1/57 (0.02)15.9 (2.1-332.7); P <.001Grade (WHO 1973 classification) INT-777 at first recurrenceGrade 1-2 = 5/15; grade 2 to cis = 1/150Unable to carry out statistical testsStage migration at first recurrenceTa-T1 = 1/15; Ta-Tis = 1/150Unable to carry out statistical testsPatients with recommended change in treatment as a result of the features of the first recurrence (% of patients within the primary risk category)14/68 (20.6) Patients changed treatment to intermediate-risk NMIBC and 1/68 (1.5) patient changed treatment to high-risk NMIBC1 (0.02%) Changed treatment to intermediate risk NMIBC15.9 (2.1-332.7); P <.001Intermediate risk (G1/G2, Ta/T1, ≥3 cm or multiple and <3 cm)16/47 (34.0)7/69 (10.2)4.6 (1.6-13.9); P <.01Grade (WHO 1973 classification) migration at first recurrence4/16 Recurrences were high-grade NMIBC2/7 Recurrences were high-grade NMIBC0.8 (0.1-9.4); P = .9Stage migration at first recurrence (% of patients with recurrence)No progression in stage was seenNo progression in stage was seenUnable to carry out statistical testsPatients with recommended change in treatment as a result of the first recurrence (% of patients within the primary risk category)4/47 (8.5%) Changed treatment to high-risk NMIBC2/69 (2.9%) Changed treatment to high-risk NMIBC3.1 (0.5-25.8); P = .2CI, confidence interval; OR, odds ratio; RRFFC, recurrence rate at first follow-up cystoscopy; WHO, World Health Organization; other abbreviations as in Table 1.Full-size tableTable optionsView in workspaceDownload as CSV